A
Antares Pharma Inc
F:MJC
Antares Pharma Inc
F:MJC
Price:
5.25
EUR
Market Cap:
€897m
Relative Value
There is not enough data to reliably calculate the relative value of MJC.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MJC
Relative Value
Base Case
Not Available
A
Multiples Across Competitors
MJC Competitors Multiples
Antares Pharma Inc Competitors
Antares Pharma Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
A
|
Antares Pharma Inc
F:MJC
|
892.9m EUR | 5.7 | 22.7 | 32.1 | 36.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
986.9B USD | 15.1 | 47.8 | 32.2 | 34.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
596.5B USD | 6.3 | 22.3 | 15.4 | 19 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
283.9B CHF | 4.7 | 30.5 | 12.9 | 15 | |
| CH |
|
Novartis AG
SIX:NOVN
|
247.6B CHF | 5.7 | 23 | 14.2 | 18.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
238.1B GBP | 5.5 | 31.5 | 17.4 | 24.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
305.9B USD | 4.7 | 16.8 | 10.4 | 12.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.9B USD | 2.5 | 20.2 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD | 2.6 | 17.8 | 7.4 | 9.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
